Verona Pharma Share Discussion Threads

[boystown] 20/12/2022 12:24

I was thinking of asking the same; what do the people who vaguely know what they're on about think this is worth? It's already valued at $960m isn't it? Seems pretty optimistic but I freely admit; I know NOTHING! :-)

[mo78000] 20/12/2022 12:12

Considering I've been in this share well over a decade do I get out if it hits $30?

[waterloo01] 20/12/2022 12:03

you're on a roll Timbo

[timbo003] 20/12/2022 11:57

Up around 25% premarket, to $16.5/share or thereabouts

[timbo003] 20/12/2022 10:59

I'll settle for that, not quite as good as ENHANCE2, as they just missed out on significance for reduction in exacerbation rate, but they are good enough, especially when you combine the data from the two studies and bingo, Clinically menaingful statistical significant reductions in exacerbations which everway you look at it

I predict a blue day for the share price

[mo78000] 20/12/2022 04:03

https://youtu.be/cIZrydkMPog

[digger18] 19/12/2022 22:39

Well after massive dilution over 12 years, I am just hoping to break even!

[mo78000] 19/12/2022 22:39

Couple of days ago someone bought 800,000 shares. Is that an indication?

[mo78000] 19/12/2022 22:37

Knowing our luck this will tank tomorrow!!

[haroldthegreat] 19/12/2022 22:27

Can I retire on the proceeds ?

[timbo003] 19/12/2022 22:06

Well spotted mo78000

Results on the second phase III study (ENHANCE 1) tomorrow then 🤞

[mo78000] 19/12/2022 21:36

https://www.veronapharma.com/media/verona-pharma-announce-top-line-data-phase-3-enhance-1-trial

[tradertrev] 16/11/2022 09:10

That presentation is a year old. Much better and more up to date presentation here:

[digger18] 15/11/2022 18:00

Good presentation!

hxxps://ether-assets.ams3.cdn.digitaloceanspaces.com/verona-pharma/VRNA-Investor-Presentation-November-2021.pdf

[mo78000] 07/11/2022 22:16

https://www.tipranks.com/news/article/these-2022-winning-stocks-can-keep-soaring-in-2023-say-analysts?utm_source=advfn.com&utm_medium=referral

[digger18] 28/10/2022 19:23

Starting to gain momentum at last!

[tradertrev] 17/10/2022 13:18

Also have much increased the (non-dilutive) debt finance through a new $150m secured debt facility, replacing the previous $30m facility with an different institution.
Now fully funded through to US market commercial launch.

[digger18] 14/10/2022 09:23

More positive data readout today, from Engance 2 trial. All looking good.

[tradertrev] 06/10/2022 08:37

Testing resistance at the last issue price of $10.50?
Enhance 1 headline data due this quarter.

[tradertrev] 30/9/2022 16:06

Under 10p?? Looking weak again?? What are you talking about? It's gone from $4 to $10 in the last 3-4 months!! Are you on the wrong thread?

[haff1] 30/9/2022 10:44

Now its under 10p this is looking weak again.....as usual...... still jam tomorrow...

[digger18] 25/8/2022 18:40

Agreed, but high confidence in the likely success of Engance 1 and they have already started to prepare for commercialisation.
They also have Dpi and MDI ready to go into P3, but I assume they will go for the profitable bronchodilator COPD maintenance market first. I am not really that concerned about a pull back between now and year end Enhance 1 results, as it would only tempt me to top up again after a partial sell. Good luck all LTH’s - it’s been a long frustrating journey.

[haff1] 25/8/2022 10:35

Whats the betting this will now return to the earlier lower levels... bit by bit?

On a TA approach it had to go back to a 10 region - following the rise - but the lower highs and lower lows now seen are all a bad sign that this is still not going to sustain a rise. It will need to keep above 10 to indicate that....lets see......